These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 21131379)

  • 1. Lack of scientific rationale for use of valproic acid for retinitis pigmentosa.
    Sandberg MA; Rosner B; Weigel-DiFranco C; Berson EL
    Br J Ophthalmol; 2011 May; 95(5):744. PubMed ID: 21131379
    [No Abstract]   [Full Text] [Related]  

  • 2. The conclusions of Clemson et al concerning valproic acid are premature.
    van Schooneveld MJ; van den Born LI; van Genderen M; Bollemeijer JG
    Br J Ophthalmol; 2011 Jan; 95(1):153; author reply 153-4. PubMed ID: 20971790
    [No Abstract]   [Full Text] [Related]  

  • 3. Authors’ response.
    Tzekov R; Bigelow C; Clemson C; Checchi J; Krebs M; Kaushal S
    Br J Ophthalmol; 2011 Aug; 95(8):1177-9. PubMed ID: 21898929
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic potential of valproic acid for retinitis pigmentosa.
    Clemson CM; Tzekov R; Krebs M; Checchi JM; Bigelow C; Kaushal S
    Br J Ophthalmol; 2011 Jan; 95(1):89-93. PubMed ID: 20647559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up for efficacy and safety of treatment of retinitis pigmentosa with valproic acid.
    Bhalla S; Joshi D; Bhullar S; Kasuga D; Park Y; Kay CN
    Br J Ophthalmol; 2013 Jul; 97(7):895-9. PubMed ID: 23603755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproic acid treatment may be harmful in non-dominant forms of retinitis pigmentosa.
    Sisk RA
    Br J Ophthalmol; 2012 Aug; 96(8):1154-5. PubMed ID: 22581401
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic use of phosphatides in retinal diseases. Preliminary communication on the behaviour of visual acuity in macular disease and retinitis pigmentosa].
    Weiss H; Kosmath B
    Klin Monbl Augenheilkd; 1971 Feb; 158(2):278-85. PubMed ID: 5555605
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term effect of acetazolamide in a patient with retinitis pigmentosa.
    Chen JC; Fitzke FW; Bird AC
    Invest Ophthalmol Vis Sci; 1990 Sep; 31(9):1914-8. PubMed ID: 2211037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of oral valproic acid in patients with retinitis pigmentosa.
    Kumar A; Midha N; Gogia V; Gupta S; Sehra S; Chohan A
    J Ocul Pharmacol Ther; 2014 Sep; 30(7):580-6. PubMed ID: 24955739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new method of treatment of retinitis pigmentosa/pigmentary abiotrophy.
    Katznelson LA; Khoroshilova-Maslova IP; Eliseyeva RF
    Ann Ophthalmol; 1990 May; 22(5):167-72. PubMed ID: 2369027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acuity recovery and cone pigment regeneration after a bleach in patients with retinitis pigmentosa and rhodopsin mutations.
    Sandberg MA; Pawlyk BS; Berson EL
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2457-61. PubMed ID: 10476820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cataract surgery in patients with retinitis pigmentosa].
    Schumacher S; Groh MJ; Naumann GO
    Klin Monbl Augenheilkd; 1998 Aug; 213(2):71-3. PubMed ID: 9782463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations.
    Sandberg MA; Rosner B; Weigel-DiFranco C; Dryja TP; Berson EL
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1298-304. PubMed ID: 17325176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of acetazolamide on visual function in retinitis pigmentosa.
    Greenstein VC; Holopigian K; Siderides E; Seiple W; Carr RE
    Invest Ophthalmol Vis Sci; 1993 Jan; 34(1):269-73. PubMed ID: 8425835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease course of patients with pericentral retinitis pigmentosa.
    Sandberg MA; Gaudio AR; Berson EL
    Am J Ophthalmol; 2005 Jul; 140(1):100-6. PubMed ID: 15953579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and treatment of Graefe-Usher syndrome].
    Katsnel'son LA; Rakhmilevich AG; Miliavskaia TI; Sadykov IuKh; Dnestrova GI
    Vestn Oftalmol; 1981; (3):41-3. PubMed ID: 7281425
    [No Abstract]   [Full Text] [Related]  

  • 17. Penicillamine--a new therapy of retinitis pigmentosa.
    Gahlot DK
    Indian J Ophthalmol; 1981 Dec; 29(4):355-8. PubMed ID: 7346458
    [No Abstract]   [Full Text] [Related]  

  • 18. The association between visual acuity and central retinal thickness in retinitis pigmentosa.
    Sandberg MA; Brockhurst RJ; Gaudio AR; Berson EL
    Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3349-54. PubMed ID: 16123439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photoreceptor integrity and visual acuity in cystoid macular oedema associated with retinitis pigmentosa.
    Oishi A; Otani A; Sasahara M; Kojima H; Nakamura H; Kurimoto M; Yoshimura N
    Eye (Lond); 2009 Jun; 23(6):1411-6. PubMed ID: 18724276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of cystoid macular edema related to retinitis pigmentosa with intravitreal triamcinolone acetonide.
    Saraiva VS; Sallum JM; Farah ME
    Ophthalmic Surg Lasers Imaging; 2003; 34(5):398-400. PubMed ID: 14509465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.